Filing Details
- Accession Number:
- 0001493152-21-013359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-01 17:10:41
- Reporting Period:
- 2021-05-28
- Accepted Time:
- 2021-06-01 17:10:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1349929 | Vyant Bio Inc. | VYNT | Services-Medical Laboratories (8071) | 043462475 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850698 | Marcus Boehm | C/O Vyant Bio, Inc. 2370 State Route 70, Suite 310 Cherry Hill, NJ 08002 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Acquisiton | 2021-05-28 | 5,000 | $3.68 | 98,929 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2021.
Billionaire Hedge Funds
